{
    "hands_on_practices": [
        {
            "introduction": "The decision to offer salvage surgery is the most critical step in managing recurrent head and neck cancer, requiring a holistic assessment that transcends simple technical resectability. This exercise challenges you to synthesize multiple, often conflicting, clinical data points—patient performance status, locoregional tumor extent, and the likelihood of distant metastatic disease—to determine if a patient is a true candidate for a curative-intent operation. Mastering this multifactorial decision-making process is essential to avoid interventions that are futile or cause unwarranted harm.",
            "id": "5068517",
            "problem": "A patient with previously irradiated oropharyngeal squamous cell carcinoma presents with a locoregional recurrence at the primary site and ipsilateral neck. The patient’s Eastern Cooperative Oncology Group (ECOG) performance status is $2$ (ambulatory and capable of self-care but unable to carry out any work activities; up and about more than $50\\%$ of waking hours). Positron Emission Tomography–Computed Tomography (PET-CT) demonstrates a nodal mass circumferentially contacting the ipsilateral internal carotid artery over approximately $220^{\\circ}$ of its circumference and two non-calcified pulmonary nodules measuring $8$ mm and $12$ mm in different lobes, fluorodeoxyglucose-avid and suspicious for metastases. There is no active major hemorrhage, airway compromise, or impending carotid blowout at presentation.\n\nUsing only fundamental oncologic surgical principles and core definitions as the base—namely: (i) salvage surgery aims for curative resection of locoregional disease in appropriately selected patients; (ii) distant metastatic disease, if confirmed, generally precludes curative salvage surgery; (iii) carotid artery encasement greater than $180^{\\circ}$ on cross-sectional imaging is a strong surrogate for arterial invasion and, in previously irradiated fields, is associated with a high risk of positive margins, stroke, and mortality with resection; and (iv) ECOG performance status of $2$ indicates increased perioperative risk and limited reserve but is not an absolute contraindication—determine the most appropriate conclusion regarding salvage surgery in this scenario.\n\nChoose the single best option:\n\nA. Proceed with immediate salvage surgery, including en bloc carotid resection with prophylactic carotid stenting, because the lung nodules are small and do not preclude curative intent.\n\nB. Salvage surgery is not indicated; prioritize establishing a tissue diagnosis of the lung nodules and, given the $220^{\\circ}$ carotid encasement and high likelihood of metastatic disease, favor systemic therapy or a clinical trial; reserve surgery for symptom palliation only if needed.\n\nC. Since ECOG is $2$, which is acceptable for major surgery, salvage resection should proceed if the patient consents, irrespective of carotid encasement or lung findings.\n\nD. Administer neoadjuvant systemic therapy to attempt to downstage carotid encasement below $180^{\\circ}$ and proceed with salvage resection if imaging improves; distant disease can be addressed after controlling the neck.",
            "solution": "**Problem Analysis**\n\nThe patient's condition presents several critical factors that must be weighed to determine the appropriateness of salvage surgery. These factors are the patient's performance status, the locoregional extent of the recurrent tumor, and the high suspicion of distant metastatic disease. The provided principles guide this analysis.\n\n1.  **Distant Disease**: The patient has two fluorodeoxyglucose (FDG)-avid pulmonary nodules suspicious for metastases. Principle (ii) states that \"distant metastatic disease, if confirmed, generally precludes curative salvage surgery.\" While these nodules are not yet biopsy-proven, their FDG avidity in a patient with known recurrent cancer confers a very high probability of metastatic disease (Stage IVc). The goal of salvage surgery, as per principle (i), is \"curative resection.\" The presence of probable distant metastases fundamentally undermines the possibility of a cure through locoregional surgery alone, shifting the goal of care from curative to palliative and the focus of treatment from local to systemic.\n\n2.  **Locoregional Disease and Resectability**: The recurrent nodal mass contacts the internal carotid artery over an arc of $220^{\\circ}$. Principle (iii) defines carotid encasement greater than $180^{\\circ}$ as a \"strong surrogate for arterial invasion,\" which, in a \"previously irradiated field,\" is associated with a \"high risk of positive margins, stroke, and mortality with resection.\" A resection that leaves a positive margin (an $R1$ or $R2$ resection) is not curative. Therefore, even ignoring the distant disease, the local disease itself is likely unresectable with curative intent ($R0$ resection). Attempting resection would be an exceedingly high-risk procedure with a low probability of oncologic success.\n\n3.  **Patient Fitness for Surgery**: The patient's Eastern Cooperative Oncology Group (ECOG) performance status is $2$. Principle (iv) notes that this indicates \"increased perioperative risk and limited reserve.\" While not an absolute contraindication, subjecting a patient with limited physiological reserve to a massive, high-risk operation (salvage neck dissection with potential carotid resection) that has little to no chance of achieving a cure is a poor clinical decision. The expected surgical morbidity would likely outweigh any potential benefit.\n\n**Synthesis**: Taken together, these three factors point strongly against pursuing salvage surgery with curative intent. The high likelihood of distant metastases makes a curative outcome unattainable by locoregional surgery. The extensive carotid involvement makes a complete ($R0$) resection of the neck disease highly improbable and the surgical attempt itself extremely dangerous. The patient's poor performance status further worsens the risk-benefit ratio of such an aggressive approach. The most logical course of action is to first confirm the systemic nature of the disease (if safely possible) and to prioritize systemic therapy, reserving any surgical intervention for palliation of acute symptoms, which the patient does not currently have.\n\n**Option-by-Option Evaluation**\n\n**A. Proceed with immediate salvage surgery, including en bloc carotid resection with prophylactic carotid stenting, because the lung nodules are small and do not preclude curative intent.**\nThis option is fundamentally flawed. It incorrectly dismisses the significance of the FDG-avid lung nodules; their size is irrelevant to their implication as distant metastases, which, according to principle (ii), would preclude curative intent. It advocates for an exceptionally high-risk surgery (carotid resection in an irradiated field) that principle (iii) warns against due to the high likelihood of positive margins and life-threatening complications. This approach ignores the patient's poor performance status (ECOG $2$) and the dismal probability of achieving a cure.\n**Verdict: Incorrect.**\n\n**B. Salvage surgery is not indicated; prioritize establishing a tissue diagnosis of the lung nodules and, given the $220^{\\circ}$ carotid encasement and high likelihood of metastatic disease, favor systemic therapy or a clinical trial; reserve surgery for symptom palliation only if needed.**\nThis option aligns perfectly with the logical synthesis of the provided principles and data. It correctly concludes that curative salvage surgery is not indicated. It appropriately prioritizes the most pressing oncologic question: confirming the presence of distant metastatic disease. It correctly identifies the two primary contraindications to curative surgery: the $220^{\\circ}$ carotid encasement (implying locoregional unresectability for cure, per principle iii) and the \"high likelihood of metastatic disease\" (per principle ii). It proposes the correct management paradigm for metastatic disease, which is systemic therapy or a clinical trial. Finally, it properly relegates surgery to a palliative role for specific indications, which are currently absent.\n**Verdict: Correct.**\n\n**C. Since ECOG is $2$, which is acceptable for major surgery, salvage resection should proceed if the patient consents, irrespective of carotid encasement or lung findings.**\nThis option gravely misinterprets the principles. Principle (iv) states ECOG $2$ is not an *absolute* contraindication, but it signifies high risk, which must be weighed against a real benefit. This option ignores the lack of benefit by disregarding the carotid encasement and lung findings, which are the central determinants of futility. Oncologic futility cannot be overridden by patient consent. Proceeding with a high-mortality surgery that cannot provide a cure is unethical and violates the principle of non-maleficence.\n**Verdict: Incorrect.**\n\n**D. Administer neoadjuvant systemic therapy to attempt to downstage carotid encasement below $180^{\\circ}$ and proceed with salvage resection if imaging improves; distant disease can be addressed after controlling the neck.**\nThis option inverts the correct oncologic priorities. In a patient with likely metastatic disease, systemic treatment is the primary modality, and the management of distant disease is the priority, not an afterthought. The strategy of \"conversion therapy\" for the neck is inappropriate when systemic disease is the dominant problem. Furthermore, the response of recurrent, irradiated cancer to systemic therapy is often poor, and post-treatment imaging is unreliable for assessing residual arterial invasion. This exposes a frail (ECOG $2$) patient to the toxicities of both systemic therapy and a major operation for a negligible chance of cure.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "After identifying a potential candidate for salvage surgery, as explored in the previous exercise , the next challenge is often confirming the diagnosis. In a previously irradiated field, differentiating tumor recurrence from treatment effects like osteoradionecrosis can be exceptionally difficult. This practice demonstrates how to move beyond clinical intuition by applying Bayesian inference, a powerful tool for quantitatively updating diagnostic certainty. By using pretest probabilities and the likelihood ratio from an imaging study, you can calculate a precise posterior probability to guide the crucial next step, such as proceeding to biopsy.",
            "id": "5068361",
            "problem": "A $62$-year-old man with previously treated oral cavity squamous cell carcinoma underwent definitive chemoradiation to a dose of $70$ Gy $18$ months ago. He now presents with progressive unilateral mandibular pain and a $1.5$ cm region of exposed lingual cortical bone in the posterior mandible. There is no frank soft-tissue mass on inspection, no spontaneous bleeding, and no pathologic fracture. Performance status is good, and there is no evidence of distant disease on staging.\n\nCross-sectional imaging with contrast-enhanced Computed Tomography (CT) shows irregular cortical erosion of the left mandible without a discrete enhancing soft-tissue mass. Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) demonstrates focal uptake in the same region with a standardized uptake value maximum (SUVmax) of $7.5$. No cervical lymphadenopathy is identified.\n\nYou are asked to apply an evidence-based salvage pathway that distinguishes post-radiation osteoradionecrosis (ORN) from tumor recurrence and determines whether immediate salvage segmental mandibulectomy is warranted. Use the following foundational facts and definitions:\n\n- Histopathology is the gold standard for diagnosing recurrence.\n- Sensitivity, specificity, and likelihood ratios are defined in the usual way, and posterior probability may be computed from prior probability using Bayes’ theorem expressed in odds form.\n- In previously irradiated mandible, FDG PET-CT is sensitive but not highly specific for differentiating recurrence from ORN. For a focal mandibular uptake with SUVmax in the range $6$ to $9$, you may assume a positive likelihood ratio of $\\text{LR}_{+} = 2.5$ and a negative likelihood ratio of $\\text{LR}_{-} = 0.4$ for recurrence versus ORN.\n- Based on cohort data in similar clinical contexts (painful exposed bone without a frank soft-tissue mass or fracture at $12$ to $24$ months post-radiation), a reasonable pretest probability for true mandibular tumor recurrence is $p_{0} = 0.30$.\n- Given the morbidity and reconstructive demands of salvage segmental mandibulectomy, institutional policy requires histologic confirmation of recurrence before resection unless there is an emergent structural complication (for example, pathologic fracture, carotid blowout risk, or rapidly progressive bleeding mass) or the posterior probability of recurrence is so high that further delay is judged unsafe.\n\nWhich of the following is the best next step with respect to determining the need for salvage segmental mandibulectomy?\n\nA. Proceed directly to salvage segmental mandibulectomy with composite resection and microvascular free flap reconstruction on the basis of the PET SUVmax of $7.5$.\n\nB. Obtain contrast-enhanced Magnetic Resonance Imaging (MRI) with Diffusion-Weighted Imaging (DWI) to look for an enhancing soft-tissue mass and perineural spread, and perform image-guided deep bone biopsy for histologic confirmation before deciding on salvage segmental mandibulectomy.\n\nC. Initiate management for osteoradionecrosis with hyperbaric oxygen and oral pentoxifylline-tocopherol-clodronate (withholding any biopsy or additional imaging), and reassess clinically in $6$ months before considering surgery.\n\nD. Assume mandibular involvement implies unresectable disease and refer the patient to systemic palliative therapy without further local diagnostic workup.",
            "solution": "To determine the best next step, we must first calculate the posterior probability of tumor recurrence given the PET-CT results and then apply the institutional policy. We will use Bayesian inference for this calculation.\n\n1.  **Determine Pretest Odds:**\n    The pretest probability of recurrence is given as $p_{0} = 0.30$. The pretest odds ($O_{pre}$) are calculated as:\n    $$O_{pre} = \\frac{p_{0}}{1 - p_{0}} = \\frac{0.30}{1 - 0.30} = \\frac{0.30}{0.70} = \\frac{3}{7}$$\n\n2.  **Apply Bayes' Theorem in Odds Form:**\n    The patient's PET-CT showed an SUVmax of $7.5$, which falls within the specified range of $6$ to $9$. This constitutes a \"positive\" test result for the purpose of this calculation. The associated positive likelihood ratio is given as $\\text{LR}_{+} = 2.5$.\n    The post-test odds ($O_{post}$) are calculated by multiplying the pretest odds by the likelihood ratio:\n    $$O_{post} = O_{pre} \\times \\text{LR}_{+}$$\n    $$O_{post} = \\frac{3}{7} \\times 2.5 = \\frac{3}{7} \\times \\frac{5}{2} = \\frac{15}{14}$$\n\n3.  **Calculate Posterior Probability:**\n    The post-test odds are converted back to a probability, which is the posterior probability of recurrence ($p_{post}$):\n    $$p_{post} = \\frac{O_{post}}{1 + O_{post}} = \\frac{15/14}{1 + 15/14} = \\frac{15/14}{29/14} = \\frac{15}{29}$$\n    As a decimal, this is approximately $p_{post} \\approx 0.517$, or a $51.7\\%$ probability.\n\n4.  **Apply Institutional Policy:**\n    The institutional policy mandates histologic confirmation before salvage mandibulectomy unless:\n    a) There is an emergent structural complication. The problem explicitly states there is no pathologic fracture, no spontaneous bleeding, and by extension, no other emergent issues. This condition is not met.\n    b) The posterior probability of recurrence is \"so high that further delay is judged unsafe\".\n\n    A posterior probability of $51.7\\%$ is far from certainty. It indicates that the chances of recurrence versus non-recurrence (i.e., ORN) are nearly equal. A $48.3\\%$ chance that the diagnosis is ORN is substantial. Subjecting a patient to a major, disfiguring surgery like a segmental mandibulectomy with a nearly $1$-in-$2$ chance that the procedure is unnecessary for cancer is not justifiable. Therefore, the posterior probability is not \"so high\" as to override the default requirement for histologic confirmation. The gold standard, biopsy with histopathology, is required.\n\n### Option-by-Option Analysis\n\n**A. Proceed directly to salvage segmental mandibulectomy with composite resection and microvascular free flap reconstruction on the basis of the PET SUVmax of $7.5$.**\nThis action implies that the posterior probability of recurrence is sufficiently high to bypass biopsy. As calculated, the posterior probability is only $51.7\\%$. This level of uncertainty does not justify immediate, highly morbid surgery. This option directly contravenes the derived conclusion and the stated institutional policy.\n**Verdict:** Incorrect.\n\n**B. Obtain contrast-enhanced Magnetic resonance Imaging (MRI) with Diffusion-Weighted Imaging (DWI) to look for an enhancing soft-tissue mass and perineural spread, and perform image-guided deep bone biopsy for histologic confirmation before deciding on salvage segmental mandibulectomy.**\nThis option correctly prioritizes obtaining a definitive diagnosis via \"image-guided deep bone biopsy for histologic confirmation\". This aligns perfectly with our conclusion that the posterior probability is not high enough to proceed directly to surgery. The additional step of obtaining an MRI with DWI is also clinically sound; it provides superior soft-tissue detail compared to CT and can help delineate any potential tumor mass from post-radiation changes, assess for perineural spread (which is critical for surgical planning), and guide the biopsy to the most suspicious area. This represents a comprehensive and evidence-based approach.\n**Verdict:** Correct.\n\n**C. Initiate management for osteoradionecrosis with hyperbaric oxygen and oral pentoxifylline-tocopherol-clodronate (withholding any biopsy or additional imaging), and reassess clinically in $6$ months before considering surgery.**\nThis option incorrectly assumes the diagnosis is ORN and proposes to defer definitive workup for recurrence for a prolonged period of $6$ months. With a posterior probability of recurrence of $51.7\\%$, delaying diagnosis poses a significant risk of allowing a potential malignancy to progress, possibly to an unresectable or metastatic state. This course of action is unsafe.\n**Verdict:** Incorrect.\n\n**D. Assume mandibular involvement implies unresectable disease and refer the patient to systemic palliative therapy without further local diagnostic workup.**\nThis option is entirely unfounded. The problem describes a localized process: a $1.5$ cm lesion with no regional or distant disease detected. Recurrent squamous cell carcinoma localized to the mandible is often treated with curative intent via salvage surgery. Declaring the disease unresectable without proper confirmation and staging is inappropriate and constitutes therapeutic nihilism.\n**Verdict:** Incorrect.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "Once the decision to operate is made and the patient is in the operating room, the focus shifts to achieving a complete oncologic resection. The cornerstone of a successful salvage operation is obtaining negative surgical margins, and the intraoperative frozen section (FS) is a key tool for real-time guidance. This exercise simulates the high-stakes environment of intraoperative decision-making, teaching you to use Bayes' theorem to interpret FS results—which have inherent limitations defined by their sensitivity and specificity—and calculate the updated probability of a positive final margin.",
            "id": "5068520",
            "problem": "A patient with recurrent oral tongue squamous cell carcinoma is undergoing salvage resection. Two intraoperative margins are evaluated by Frozen Section (FS): a mucosal margin and a deep margin. Institutional salvage-specific data provide subsite-specific pretest probabilities for final pathology margin positivity of $p_{\\text{muc}} = 0.12$ for the mucosal margin and $p_{\\text{deep}} = 0.25$ for the deep margin. The FS characteristics in this salvage oral cavity setting are: mucosal margin sensitivity $s_{\\text{muc}} = 0.86$ and specificity $c_{\\text{muc}} = 0.95$; deep margin sensitivity $s_{\\text{deep}} = 0.72$ and specificity $c_{\\text{deep}} = 0.88$. During the operation, the FS on the mucosal margin is positive, and the FS on the deep margin is negative. Assume that, conditional on the true status of each margin, FS results are independent across margins and that the true statuses of the mucosal and deep margins are independent given subsite-specific risk.\nUsing the definition of sensitivity and specificity as well-tested measures of test performance, and Bayes’ theorem as the fundamental probabilistic rule relating pretest probability to post-test probability, compute the posterior probability that the final pathology will show at least one positive margin (i.e., a positive final margin) given these mixed FS results. Express your result as a decimal and round your answer to four significant figures.",
            "solution": "Let us define the events and parameters based on the problem statement.\nLet $M_{true}$ be the event that the true mucosal margin is positive, and $M_{false}$ be the event that it is negative.\nLet $D_{true}$ be the event that the true deep margin is positive, and $D_{false}$ be the event that it is negative.\nThe pretest probabilities (priors) are given as:\n$P(M_{true}) = p_{\\text{muc}} = 0.12$\n$P(D_{true}) = p_{\\text{deep}} = 0.25$\nFrom these, we can deduce the probabilities of negative true margins:\n$P(M_{false}) = 1 - P(M_{true}) = 1 - 0.12 = 0.88$\n$P(D_{false}) = 1 - P(D_{true}) = 1 - 0.25 = 0.75$\n\nLet $FS_{M+}$ be the event of a positive Frozen Section (FS) result on the mucosal margin, and $FS_{M-}$ be the event of a negative result.\nLet $FS_{D+}$ be the event of a positive FS result on the deep margin, and $FS_{D-}$ be the event of a negative result.\n\nThe diagnostic test characteristics are given as sensitivities ($s$) and specificities ($c$):\nSensitivity for the mucosal margin: $s_{\\text{muc}} = P(FS_{M+} | M_{true}) = 0.86$\nSpecificity for the mucosal margin: $c_{\\text{muc}} = P(FS_{M-} | M_{false}) = 0.95$\nSensitivity for the deep margin: $s_{\\text{deep}} = P(FS_{D+} | D_{true}) = 0.72$\nSpecificity for the deep margin: $c_{\\text{deep}} = P(FS_{D-} | D_{false}) = 0.88$\n\nFrom these, we can derive the probabilities of false positives and false negatives:\n$P(FS_{M+} | M_{false}) = 1 - c_{\\text{muc}} = 1 - 0.95 = 0.05$\n$P(FS_{M-} | M_{true}) = 1 - s_{\\text{muc}} = 1 - 0.86 = 0.14$\n$P(FS_{D+} | D_{false}) = 1 - c_{\\text{deep}} = 1 - 0.88 = 0.12$\n$P(FS_{D-} | D_{true}) = 1 - s_{\\text{deep}} = 1 - 0.72 = 0.28$\n\nThe evidence, which we denote as $E$, consists of the observed FS results: a positive mucosal margin and a negative deep margin.\n$E = FS_{M+} \\cap FS_{D-}$\n\nThe goal is to compute the posterior probability that at least one margin is truly positive, given the evidence $E$. This can be written as $P(M_{true} \\cup D_{true} | E)$.\n\nIt is computationally more direct to calculate the probability of the complementary event: that both margins are truly negative, given the evidence. We can then subtract this from $1$.\n$P(M_{true} \\cup D_{true} | E) = 1 - P(M_{false} \\cap D_{false} | E)$\n\nThe problem states two key independence assumptions:\n1. The true statuses of the margins are independent: $P(M_i \\cap D_j) = P(M_i)P(D_j)$ for $i,j \\in \\{true, false\\}$.\n2. Conditional on the true status, the FS results are independent: $P(FS_{M_x} \\cap FS_{D_y} | M_i \\cap D_j) = P(FS_{M_x} | M_i)P(FS_{D_y} | D_j)$ for $x,y \\in \\{+,-\\}$.\n\nThese assumptions imply that the posterior probabilities for each margin are also independent. That is, $P(M_{false} \\cap D_{false} | E) = P(M_{false} | FS_{M+}) \\times P(D_{false} | FS_{D-})$. We will calculate each of these posterior probabilities separately using Bayes' theorem.\n\nFirst, we calculate the posterior probability that the mucosal margin is truly negative, given a positive FS result, $P(M_{false} | FS_{M+})$.\n$$ P(M_{false} | FS_{M+}) = \\frac{P(FS_{M+} | M_{false}) P(M_{false})}{P(FS_{M+})} $$\nThe denominator, $P(FS_{M+})$, is the total probability of a positive mucosal FS, calculated by the law of total probability:\n$P(FS_{M+}) = P(FS_{M+} | M_{true})P(M_{true}) + P(FS_{M+} | M_{false})P(M_{false})$\n$P(FS_{M+}) = (s_{\\text{muc}})(p_{\\text{muc}}) + (1 - c_{\\text{muc}})(1 - p_{\\text{muc}})$\n$P(FS_{M+}) = (0.86)(0.12) + (0.05)(0.88) = 0.1032 + 0.044 = 0.1472$\nNow we can compute the posterior probability:\n$P(M_{false} | FS_{M+}) = \\frac{(0.05)(0.88)}{0.1472} = \\frac{0.044}{0.1472}$\n\nSecond, we calculate the posterior probability that the deep margin is truly negative, given a negative FS result, $P(D_{false} | FS_{D-})$.\n$$ P(D_{false} | FS_{D-}) = \\frac{P(FS_{D-} | D_{false}) P(D_{false})}{P(FS_{D-})} $$\nThe denominator, $P(FS_{D-})$, is the total probability of a negative deep FS:\n$P(FS_{D-}) = P(FS_{D-} | D_{true})P(D_{true}) + P(FS_{D-} | D_{false})P(D_{false})$\n$P(FS_{D-}) = (1 - s_{\\text{deep}})(p_{\\text{deep}}) + (c_{\\text{deep}})(1 - p_{\\text{deep}})$\n$P(FS_{D-}) = (0.28)(0.25) + (0.88)(0.75) = 0.07 + 0.66 = 0.73$\nNow we can compute the posterior probability:\n$P(D_{false} | FS_{D-}) = \\frac{(0.88)(0.75)}{0.73} = \\frac{0.66}{0.73}$\n\nNow, we combine these results to find the probability that both margins are truly negative given the evidence.\n$P(M_{false} \\cap D_{false} | E) = P(M_{false} | FS_{M+}) \\times P(D_{false} | FS_{D-})$\n$P(M_{false} \\cap D_{false} | E) = \\left(\\frac{0.044}{0.1472}\\right) \\times \\left(\\frac{0.66}{0.73}\\right)$\n$P(M_{false} \\cap D_{false} | E) \\approx (0.29891304) \\times (0.90410959) \\approx 0.27025805$\n\nFinally, the desired probability of at least one positive true margin is $1$ minus this value.\n$P(M_{true} \\cup D_{true} | E) = 1 - P(M_{false} \\cap D_{false} | E)$\n$P(M_{true} \\cup D_{true} | E) \\approx 1 - 0.27025805 \\approx 0.72974195$\n\nRounding the result to four significant figures, we get $0.7297$.",
            "answer": "$$\n\\boxed{0.7297}\n$$"
        }
    ]
}